Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB02546"

No prefix for http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/.
PredicateValue (sorted: none)
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
ns1:interactsWith
rdf:type
ns1:interactsWith
owl:sameAs
ns1:drugCategory
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
rdfs:label
"Vorinostat"
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
ns1:description
"Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA), is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors. A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned in which vorinostat will be combined with other drugs. [Wikipedia]"
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
ns1:drugCategory
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
ns1:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
ns1:interactsWith
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
ns1:interactsWith
owl:sameAs
ns1:interactsWith
owl:sameAs

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt

The resource appears as object in 153 triples

Context graph